P631 Development and validation of a clinical scoring tool for predicting treatment outcomes with vedolizumab in patients with ulcerative colitis
Dulai, P S, Singh, S, Vande Casteele, N, Meserve, J, Winters, A, Chablaney, S, Aniwan, S, Shashi, P, Kochhar, G, Weiss, A, Koliani-Pace, J L, Gao, Y, Boland, B S, Chang, J T, Faleck, D, Hirten, R, Ungaro, R, Lukin, D, Sultan, K, Hudesman, D, Chang, S, Bohm, M, Varma, S, Fischer, M, Shmidt, E, Swaminath, A, Gupta, N, Rosario, M, Jairath, V, Guizzetti, L, Feagan, B G, Siegel, C A, Shen, B, Kane, S, Loftus Jr, E V, Sandborn, W J, Sands, B E, Colombel, J-F, Lasch, K, Cao, C
Published in Journal of Crohn's and colitis (25.01.2019)
Published in Journal of Crohn's and colitis (25.01.2019)
Get full text
Journal Article
DOP009 Comparative safety profile of vedolizumab and tumour necrosis factor–antagonist therapy for inflammatory bowel disease: a multicentre consortium propensity score-matched analysis
Lukin, D, Weiss, A, Aniwan, S, Kadire, S, Tran, G, Rahal, M, Faleck, D, Winters, A, Chablaney, S, Meserve, J, Kochhar, G, Shashi, P, Koliani-Pace, J L, Bohm, M, Sagi, S V, Fischer, M, Boland, B, Singh, S, Hirten, R, Shmidt, E, Hudesman, D, Chang, S, Sultan, K, Swaminath, A, Gupta, N, Kane, S, Loftus, E V, Shen, B, Sands, B E, Sandborn, W J, Colombel, J -F, Siegel, C A, Dulai, P S
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article
DOP006 A multicentre cohort study to assess the safety of vedolizumab for inflammatory bowel disease
Meserve, J, Aniwan, S, Koliani-Pace, J L, Shashi, P, Weiss, A, Faleck, D, Winters, A, Chablaney, S, Kochhar, G, Boland, B, Singh, S, Hirten, R, Shmidt, E, Bohm, M, Sagi, S V, Fischer, M, Lukin, D, Hudesman, D, Chang, S, Sultan, K, Swaminath, A, Gupta, N, Kane, S, Loftus, E V, Shen, B, Sands, B E, Colombel, J -F, Siegel, C A, Sandborn, W J, Dulai, P S
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article
DOP053 Impact of concomitant immunomodulator use on vedolizumab effectiveness: a multicentre consortium propensity score-matched analysis
Hudesman, D, Chang, S, Shashi, P, Winters, A, Chablaney, S, Meserve, J, Weiss, A, Aniwan, S, Faleck, D, Koliani-Pace, J L, Kochhar, G, Boland, B, Singh, S, Hirten, R, Shmidt, E, Lasch, K, Luo, M, Bohm, M, Sagi, S V, Fischer, M, Lukin, D, Sultan, K, Swaminath, A, Gupta, N, Siegel, C A, Shen, B, Kane, S, Loftus, E V, Sands, B E, Sandborn, W J, Colombel, J -F, Dulai, P S
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article
DOP051 Shorter disease duration is associated with higher response rates to vedolizumab in Crohn’s disease but not ulcerative colitis: a multi-centre consortium analysis
Faleck, D, Winters, A, Chablaney, S, Shashi, P, Meserve, J, Weiss, A, Aniwan, S, Koliani-Pace, J L, Kochhar, G, Boland, B, Singh, S, Hirten, R, Shmidt, E, Lasch, K, Luo, M, Bohm, M, Sagi, S V, Fischer, M, Hudesman, D, Chang, S, Lukin, D, Sultan, K, Swaminath, A, Gupta, N, Siegel, C A, Shen, B, Sandborn, W J, Kane, S, Loftus, E V, Sands, B E, Colombel, J -F, Dulai, P S, Ungaro, R
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article
OP025 Comparative effectiveness of vedolizumab and tumour necrosis factor-antagonist therapy in Crohn’s disease: a multicentre consortium propensity score-matched analysis
Bohm, M, Sagi, S V, Fischer, M, Kadire, S, Tran, G, Rahal, M, Aniwan, S, Meserve, J, Weiss, A, Kochhar, G, Shashi, P, Faleck, D, Winters, A, Chablaney, S, Koliani-Pace, J L, Boland, B, Singh, S, Hirten, R, Shmidt, E, Lasch, K, Luo, M, Hudesman, D, Chang, S, Lukin, D, Sultan, K, Swaminath, A, Gupta, N, Siegel, C A, Kane, S, Loftus, E V, Sands, B E, Sandborn, W J, Colombel, J -F, Shen, B, Dulai, P S
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article
OP026 Comparative effectiveness of vedolizumab and TNF-antagonist therapy in ulcerative colitis: a multicentre consortium propensity score-matched analysis
Faleck, D, Shashi, P, Meserve, J, Rahal, M, Kadire, S, Tran, G, Weiss, A, Winters, A, Chablaney, S, Aniwan, S, Koliani-Pace, J L, Kochhar, G, Boland, B, Singh, S, Hirten, R, Shmidt, E, Lasch, K, Luo, M, Bohm, M, Sagi, S V, Fischer, M, Hudesman, D, Chang, S, Lukin, D, Sultan, K, Swaminath, A, Gupta, N, Siegel, C A, Shen, B, Sandborn, W J, Sands, B E, Colombel, J -F, Kane, S, Loftus, E V, Dulai, P S
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article